Physician profile

Amanda Medley

Psychiatric/Mental Health (Nurse Practitioner) · Elizabethtown, KY

NPI 1538620356

$14,007.27

in general payments reported to CMS, 2019-2025

27 companies · $2,046 in 2025

The $2,046 reported for 2025 was more than what 92% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).

See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7,478.22
Honoraria$1,650.00
Travel and Lodging$1,240.03
Education$5.15

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Supernus Pharmaceuticals, INC. $4,806.51 2021-2025 Qelbree, Qelbree
Abbvie INC. $1,213.70 2021-2025
Otsuka America Pharmaceutical, INC. $938.54 2021-2025 Rexulti, Abilify Maintena, Abilify Asimtufii
Corium, LLC $932.69 2021-2025 Azstarys
Vanda Pharmaceuticals INC. $878.42 2021-2025 Fanapt, Hetlioz
Lundbeck LLC $812.98 2021-2025 Abilify Maintena, Rexulti, Abilify Asimtufii
Teva Pharmaceuticals USA, INC. $802.60 2022-2025 Austedo Xr, Austedo, Uzedy
Alkermes, INC. $797.01 2021-2025 Aristada, Lybalvi
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $618.84 2021-2025 Caplyta
Takeda Pharmaceuticals U.S.A., INC. $363.99 2021-2023 Trintellix
Sunovion Pharmaceuticals INC. $321.99 2021-2022
Axsome Therapeutics, INC. $215.36 2022-2025 Auvelity
Janssen Pharmaceuticals, INC $200.53 2021-2025 Spravato
E.R. Squibb & Sons, L.L.C. $161.75 2025 Cobenfy
Indivior INC. $159.37 2021-2024 Sublocade, Perseris
Show all 27 companies
CompanyGeneral paymentsYearsTop products
Neurocrine Biosciences, INC. $158.42 2022-2025 Ingrezza
Ironshore Pharmaceuticals INC. $111.97 2022-2024 Jornay Pm
Noven Therapeutics, LLC $96.88 2024-2025 Xelstrym
Uswm, LLC $92.93 2022-2023 Lucemyra, Zimhi
Tris Pharma INC $90.14 2021-2023 Dyanavel Xr
Biogen, INC. $80.20 2025 Zurzuvae
Idorsia Pharmaceuticals US INC $52.49 2023 Quviviq
Neuronetics, INC. $28.86 2025 Neurostar Tms Therapy System
Bausch Health US, LLC $23.65 2022
Otsuka Pharmaceutical Development & Commercialization, INC. $16.24 2025 Rejoyn
Gilead Sciences, INC. $15.86 2022
Bioventus LLC $15.35 2025 Durolane

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Amanda Medley

$14,007.27

in general payments reported 2019-2025

Years
2021-2025
Top company
Supernus Pharmaceuticals, INC.
Context
The $2,046 reported for 2025 was more than what 92% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).

https://glasscript.com/doctor/11221377/amanda-medley

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.